Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects-Reference-Cited by-同舟云学术

Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects

Published:2020-01 Issue:1 Volume:6 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Malekizadeh Yasaman¹,Williams Gareth²,Kelson Mark³,Whitfield David¹,Mill Jonathan¹,Collier David A.⁴,Ballard Clive¹,Jeffries Aaron R.¹,Creese Byron¹

Affiliation:

1. College of Medicine and Health University of Exeter Medical School University of Exeter Exeter UK

2. College of Engineering Mathematics and Physical Sciences University of Exeter Exeter UK

3. Wolfson Centre for Age‐Related Disease Institute of Psychiatry, Psychology and Neuroscience King's College London London UK

4. Eli Lilly and Company Ltd Erl Wood Manor Surrey UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12078

Reference36 articles.

1. Neuroleptic drugs in dementia: benefits and harm

2. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer’s disease

3. Risk of cerebrovascular events in elderly users of antipsychotics

4. Do Atypical Antipsychotics Cause Stroke?

5. Association Between Risperidone Treatment and Cerebrovascular Adverse Events: Examining the Evidence and Postulating Hypotheses for an Underlying Mechanism

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropsychiatric Manifestations in Alzheimer’s Disease Patients: Genetics and Treatment Options;CNS & Neurological Disorders - Drug Targets;2024-01

2. Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update;Drugs & Aging;2022-12-14

3. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines;Frontiers in Neuroscience;2022-11-15

4. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions;Journal of Alzheimer's Disease;2022-08-16

5. Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic Approach;Biomedicines;2022-05-24